Literature DB >> 24842915

Different expression of 11β-hydroxylase and aldosterone synthase between aldosterone-producing microadenomas and macroadenomas.

Yoshikiyo Ono1, Yasuhiro Nakamura1, Takashi Maekawa1, Saulo J A Felizola1, Ryo Morimoto1, Yoshitsugu Iwakura1, Masataka Kudo1, Kazumasa Seiji1, Kei Takase1, Yoichi Arai1, Celso E Gomez-Sanchez1, Sadayoshi Ito1, Hironobu Sasano1, Fumitoshi Satoh2.   

Abstract

Aldosterone-producing adenoma is a major subtype of primary aldosteronism. The number of cases of these adenomas, which are below the detection limit of computed tomography but diagnosed by adrenal venous sampling, has recently been increasing. However, the pathophysiology of these adenomas, especially those manifesting clinically overt hyperaldosteronism despite their small size, remains unknown. Therefore, we examined the correlation between tumor size and the status of intratumoral steroidogenic enzymes involved in aldosterone biosynthesis using immunohistochemistry. Forty patients with surgically proven aldosterone-producing adenomas were retrospectively studied. Multidetector computed tomography, adrenal venous sampling, and laparoscopic adrenalectomy were performed in all of the patients studied. The tumor area at the maximum diameter of the sections was precisely measured by ImageJ software. The status of the steroidogenic enzymes was immunohistochemically analyzed, and the findings were evaluated according to the H-score system, based on both the number of immunopositive cells and relative immunointensity. Adrenal masses were not detected by computed tomography in 20 patients. Blood pressure, plasma aldosterone concentration, urinary aldosterone excretion, and the number of antihypertensive agents also decreased significantly after the surgery in these patients, as well as in the patients with adenomas detectable by computed tomography. Maximum tumor area obtained in the specimens was significantly correlated with preoperative plasma aldosterone concentration, urinary aldosterone excretion, and the H score of 11β-hydroxylase and was inversely correlated with the H score of aldosterone synthase. These results demonstrated that small adenomas could produce sufficient aldosterone to cause clinically overt primary aldosteronism because of the significantly higher aldosterone synthase expression per tumor area.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  CYP11B1; CYP11B2; adrenocortical adenoma; hyperaldosteronism; hypertension; immunohistochemistry

Mesh:

Substances:

Year:  2014        PMID: 24842915      PMCID: PMC5478923          DOI: 10.1161/HYPERTENSIONAHA.113.02944

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  28 in total

1.  Hyperaldosteronism among black and white subjects with resistant hypertension.

Authors:  David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Roopal B Thakkar; Paula Weissmann
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

2.  Role for adrenal venous sampling in primary aldosteronism.

Authors:  William F Young; Anthony W Stanson; Geoffrey B Thompson; Clive S Grant; David R Farley; Jon A van Heerden
Journal:  Surgery       Date:  2004-12       Impact factor: 3.982

3.  Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.

Authors:  C E Fardella; L Mosso; C Gómez-Sánchez; P Cortés; J Soto; L Gómez; M Pinto; A Huete; E Oestreicher; A Foradori; J Montero
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

Review 4.  A review of the medical treatment of primary aldosteronism.

Authors:  P O Lim; W F Young; T M MacDonald
Journal:  J Hypertens       Date:  2001-03       Impact factor: 4.844

5.  Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases.

Authors:  Yoshitsugu Iwakura; Ryo Morimoto; Masataka Kudo; Yoshikiyo Ono; Kei Takase; Kazumasa Seiji; Yoichi Arai; Yasuhiro Nakamura; Hironobu Sasano; Sadayoshi Ito; Fumitoshi Satoh
Journal:  J Clin Endocrinol Metab       Date:  2013-11-27       Impact factor: 5.958

Review 6.  Role of KCNJ5 in familial and sporadic primary aldosteronism.

Authors:  Paolo Mulatero; Silvia Monticone; William E Rainey; Franco Veglio; Tracy Ann Williams
Journal:  Nat Rev Endocrinol       Date:  2012-12-11       Impact factor: 43.330

7.  Determining the accuracy of blood pressure measurement by the Omron HEM-907 before and after hemodialysis.

Authors:  Marek Czarkowski; Monika Staszków; Kacper Kostyra; Zuhier Shebani; Stanisław Niemczyk; Joanna Matuszkiewicz-Rowińska
Journal:  Blood Press Monit       Date:  2009-10       Impact factor: 1.444

8.  Differential effects of high and low steroidogenic factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells.

Authors:  Ping Ye; Yashuhiro Nakamura; Enzo Lalli; William E Rainey
Journal:  Endocrinology       Date:  2008-10-30       Impact factor: 4.736

9.  The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production.

Authors:  Mary H Bassett; Takashi Suzuki; Hironobu Sasano; Perrin C White; William E Rainey
Journal:  Mol Endocrinol       Date:  2003-11-26

10.  Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry.

Authors:  E Born-Frontsberg; M Reincke; L C Rump; S Hahner; S Diederich; R Lorenz; B Allolio; J Seufert; C Schirpenbach; F Beuschlein; M Bidlingmaier; S Endres; M Quinkler
Journal:  J Clin Endocrinol Metab       Date:  2009-02-03       Impact factor: 5.958

View more
  17 in total

1.  Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series.

Authors:  Francesco Fallo; Isabella Castellano; Celso E Gomez-Sanchez; Yara Rhayem; Catia Pilon; Valentina Vicennati; Donatella Santini; Valeria Maffeis; Ambrogio Fassina; Paolo Mulatero; Felix Beuschlein; Martin Reincke
Journal:  Endocrine       Date:  2017-04-12       Impact factor: 3.633

2.  Histopathological Classification of Cross-Sectional Image-Negative Hyperaldosteronism.

Authors:  Yuto Yamazaki; Yasuhiro Nakamura; Kei Omata; Kazue Ise; Yuta Tezuka; Yoshikiyo Ono; Ryo Morimoto; Yukinaga Nozawa; Celso E Gomez-Sanchez; Scott A Tomlins; William E Rainey; Sadayoshi Ito; Fumitoshi Satoh; Hironobu Sasano
Journal:  J Clin Endocrinol Metab       Date:  2017-04-01       Impact factor: 5.958

Review 3.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Authors:  Anand Vaidya; Paolo Mulatero; Rene Baudrand; Gail K Adler
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

4.  Rapid Screening of Primary Aldosteronism by a Novel Chemiluminescent Immunoassay.

Authors:  Ryo Morimoto; Yoshikiyo Ono; Yuta Tezuka; Masataka Kudo; Sachiko Yamamoto; Toshiaki Arai; Celso E Gomez-Sanchez; Hironobu Sasano; Sadayoshi Ito; Fumitoshi Satoh
Journal:  Hypertension       Date:  2017-06-26       Impact factor: 10.190

5.  H-score of 11β-hydroxylase and aldosterone synthase in the histopathological diagnosis of adrenocortical tumors.

Authors:  Yi Yang; Ming Xiao; Ying Song; Yi Tang; Ting Luo; Shumin Yang; Wenwen He; Qingfeng Cheng; Linqiang Ma; Yao Zhang; Yunfeng He; Youde Cao; Jun Yang; Bin Peng; Jinbo Hu; Qifu Li
Journal:  Endocrine       Date:  2019-07-22       Impact factor: 3.633

6.  Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism.

Authors:  Fumitoshi Satoh; Ryo Morimoto; Yoshikiyo Ono; Yoshitsugu Iwakura; Kei Omata; Masataka Kudo; Kei Takase; Kazumasa Seiji; Hidehiko Sasamoto; Seijiro Honma; Mitsunobu Okuyama; Kouwa Yamashita; Celso E Gomez-Sanchez; William E Rainey; Yoichi Arai; Hironobu Sasano; Yasuhiro Nakamura; Sadayoshi Ito
Journal:  Hypertension       Date:  2015-03-16       Impact factor: 10.190

7.  Tumor Cell Subtypes Based on the Intracellular Hormonal Activity in KCNJ5-Mutated Aldosterone-Producing Adenoma.

Authors:  Yuto Yamazaki; Kei Omata; Yuta Tezuka; Yoshikiyo Ono; Ryo Morimoto; Yuzu Adachi; Kazue Ise; Yasuhiro Nakamura; Celso E Gomez-Sanchez; Yukiko Shibahara; Takumi Kitamoto; Tetsuo Nishikawa; Sadayoshi Ito; Fumitoshi Satoh; Hironobu Sasano
Journal:  Hypertension       Date:  2018-09       Impact factor: 10.190

8.  Intratumoral heterogeneity of steroidogenesis in aldosterone-producing adenoma revealed by intensive double- and triple-immunostaining for CYP11B2/B1 and CYP17.

Authors:  Yasuhiro Nakamura; Masaaki Kitada; Fumitoshi Satoh; Takashi Maekawa; Ryo Morimoto; Yuto Yamazaki; Kazue Ise; Celso E Gomez-Sanchez; Sadayoshi Ito; Yoichi Arai; Mari Dezawa; Hironobu Sasano
Journal:  Mol Cell Endocrinol       Date:  2015-11-17       Impact factor: 4.102

Review 9.  Adrenal histopathology in primary aldosteronism: is it time for a change?

Authors:  Francesca Gioco; Teresa Maria Seccia; Elise P Gomez-Sanchez; Gian Paolo Rossi; Celso E Gomez-Sanchez
Journal:  Hypertension       Date:  2015-08-03       Impact factor: 10.190

10.  Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.

Authors:  Silvia Monticone; Isabella Castellano; Karine Versace; Barbara Lucatello; Franco Veglio; Celso E Gomez-Sanchez; Tracy A Williams; Paolo Mulatero
Journal:  Mol Cell Endocrinol       Date:  2015-05-06       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.